Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-11-02
1987-08-25
Foelak, Morton
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 435235, 435948, A61K 3912
Patent
active
046892257
ABSTRACT:
A novel subunit vaccine employing glycoprotein A of human cytomegalovirus or fragments thereof is provided. The vaccine is particularly suitable for inoculation of immunosuppressed individuals and women of childbearing age to inhibit the transmission of hCMV to the fetus.
REFERENCES:
patent: 3959466 (1976-05-01), Plotkin
patent: 4058598 (1977-11-01), Stern et al.
patent: 4452734 (1984-06-01), Larson et al.
Pereira et al, "Polymorphism of Human Cytomegalovirus . . . MAB", J. Virol., 139, 1984, pp. 73-86.
Pereira et al., Infect. and Imm., vol. 36(3), 1982, pp. 924-942.
Stagno et al, "Congenital Cytomegalovirus Infection", N. Eng. J. Med., vol. 296(22), 1979, pp. 1254-1258.
Starr et al, "Specific Cellular and Humarol Immunity after Immunization . . . Vaccine", J. Inf. Dis., 143(4), 1981, pp. 585-589.
Virology, 2nd Ed., Joklik, 1985, pp. 207-210.
Pereira et al. (1983) Infection and Immunology 39:100-108.
Draper Garnette D.
Foelak Morton
Institut Merieux
Rowland Bertram I.
LandOfFree
Vaccine for cytomegalovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for cytomegalovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for cytomegalovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1922427